Gene expression profiling reveals the mechanism of action of anticonvulsant drug QYS

被引:20
|
作者
Li, XC [1 ]
Hu, YH [1 ]
机构
[1] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China
关键词
Qingyangshenylycosides (QYS); audiogenic seizure (AGS); anticonvulsant drug; gene expression; Scn1b; metabolic enzyme;
D O I
10.1016/j.brainresbull.2005.03.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have examined the gene expression profiling of inferior colliculus from DBA/2J mice with high-intensity noise induced audiogenic seizure (AGS). We have also tested the effects of Qingyangshenylycosides (QYS), a traditional Chinese medicine, on the audiogenic seizure, and examined how the drug affected the gene expressions in inferior colliculus. Our results demonstrated that the latency was increased and the Tonus% of AGS was decreased in the animals treated with QYS, indicating that the drug effectively prevented audiogenic seizure. Gene expression analysis using Agilent oligo microarray showed that total of 134 genes were either up- or down-regulated during AGS. QYS prevented many of the AGS induced gene expression changes. Nevertheless, some of the AGS induced genes were further enhanced or reversed by QYS treatment. Our gene expression profiling data provided important information regarding the molecular mechanisms of AGS and the mechanism of action of QYS. Further analysis of the function of these genes may help to identify therapeutic targets for epilepsy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 50 条
  • [12] ANTICONVULSANT DRUG MECHANISMS OF ACTION
    MACDONALD, RL
    MCLEAN, MJ
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1985, 61 (03): : S16 - S17
  • [13] Mechanism of action analysis of IMiDs using global and focused gene expression profiling.
    Brady, HA
    Richard, N
    deParseval, L
    Corral, L
    Wu, J
    Glezer, E
    Aminpour, R
    Mercurio, F
    Chan, K
    BLOOD, 2003, 102 (11) : 162B - 162B
  • [14] ANTICONVULSANT DRUG MECHANISMS OF ACTION
    MACDONALD, RL
    MCLEAN, MJ
    SKERRITT, JH
    FEDERATION PROCEEDINGS, 1985, 44 (10) : 2634 - 2639
  • [15] MECHANISM OF ANTICONVULSANT ACTION OF DIAZEPAM
    OSTROVSKAYA, RU
    MOLODAVKIN, GM
    PORFIREVA, RP
    ZUBOVSKAYA, AM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1975, 79 (03) : 270 - 273
  • [16] Gene expression profiling reveals candidate biomarkers and probable molecular mechanism in diabetic peripheral neuropathy
    Zhou, Han
    Zhang, WenChuan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1213 - 1223
  • [18] The role of gene expression profiling in drug discovery
    Bates, Stewart
    CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (05) : 549 - 556
  • [19] Gene expression profiling in drug discovery and development
    Stratowa, C
    Wilgenbus, KK
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 1999, 1 (06) : 671 - 679
  • [20] The characterization of PPARα ligand drug action in an in vivo model by comprehensive differential gene expression profiling
    Gould Rothberg B.E.
    Sundseth S.S.
    DiPippo V.A.
    Brown P.J.
    Winegar D.A.
    Gottshalk W.K.
    Shenoy S.G.
    Rothberg J.M.
    Functional & Integrative Genomics, 2001, 1 (5) : 294 - 304